Polygenic breast cancer risk scores strive to overcome racial biasAugust 24, 2021Breast CancerMetastatic Breast Cancer
Key strategies for managing breast cancer brain metastasesJune 17, 2021Metastatic Breast CancerBreast Cancer
CONCERT: Better QoL but not survival with cabazitaxel in metastatic HER2– breast cancerJune 7, 2021Breast CancerMetastatic Breast Cancer
IL-6 levels predict distant breast cancer recurrenceJune 4, 2021Metastatic Breast CancerBreast Cancer
Trastuzumab deruxtecan-related lung disease in MBC patients can occur anytime in first yearJune 2, 2021Metastatic Breast CancerBreast Cancer
Endocrine therapy benefits in premenopausal breast cancer differ by molecular riskMay 26, 2021Breast CancerMetastatic Breast Cancer
Evolving strategies in sequencing for HER2+ MBC therapyMay 25, 2021Metastatic Breast CancerBreast Cancer
New targeted treatments are major advances for HER2-positive breast cancerMay 21, 2021Breast CancerMetastatic Breast Cancer
GELATO trial: Chemoimmunotherapy may help in metastatic invasive lobular breast cancerMay 19, 2021Metastatic Breast CancerBreast Cancer
FDA panel votes against 2 cancer indications but backs 4 of 6April 30, 2021Breast CancerMetastatic Breast Cancer
FDA panel backs atezolizumab for mTNBC – at least for nowApril 28, 2021Breast CancerMetastatic Breast Cancer
Cell-free DNA improves response prediction in breast cancerApril 21, 2021Breast CancerMetastatic Breast Cancer
